NOVOEIGHT
antihemophilic factor recombinant · KIT · Novo Nordisk
Novoeight is a recombinant antihemophilic factor used to treat hemophilia A by replacing the missing or deficient blood clotting factor VIII. It comes as a kit for injection and helps prevent or stop bleeding episodes in people with this inherited bleeding disorder.
Key Facts
- Brand Name
- NOVOEIGHT
- Generic Name
- antihemophilic factor recombinant
- NDC Code (Product)
0169-7820- Manufacturer
- Novo Nordisk
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125466
- Marketing Start
- 04/01/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is NOVOEIGHT used for?
Novoeight is a recombinant antihemophilic factor used to treat hemophilia A by replacing the missing or deficient blood clotting factor VIII. It comes as a kit for injection and helps prevent or stop bleeding episodes in people with this inherited bleeding disorder.
Is NOVOEIGHT a controlled substance?
NOVOEIGHT is not classified as a controlled substance by the DEA.
What is the generic name for NOVOEIGHT?
The generic name for NOVOEIGHT is antihemophilic factor recombinant. There are 5 other brand versions of antihemophilic factor recombinant.
What is the NDC code for NOVOEIGHT ?
The NDC (National Drug Code) for NOVOEIGHT is 0169-7820, listed by Novo Nordisk.